Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ACRO
CRO
ARPA-H unveils Surpass program to accelerate clinical trials
The initiatives aim to speed up clinical trials by modernizing clinical development, reducing delays and costs and strengthening U.S. competitiveness.
Marissa Russo
Oct 7, 2026 11:25am
ACRO unveils Q&A tool to speed adoption of decentralized trials
Oct 20, 2022 5:00am
ACRO posts principles to tackle age-old clinical trial problem
Aug 26, 2022 10:13am
Brexit ‘could be an opportunity for U.K. clinical research’
Nov 29, 2018 10:29am
Covance CEO Ratliff elected 2018 ACRO chairman
Jan 29, 2018 9:45am
ACRO urges government to allow CRO tax credits
Nov 16, 2017 4:35am